NAT10 and hepatocellular carcinoma: Furthermore, NAT10’s lysine acetyltransferase activity contributes to chemoresistance in hepatocellular carcinoma, NAT10 acetylates ACLY to boost nuclear acetyl-CoA production, enabling transcriptional activation of drug resistance genes [74].